Schott Pharma & (1SXP.DE) traded down -0.78 % during a 24 hours period ending at 05:48 PM Central Europe on Tuesday 27th. One Schott Pharma & stock can currently be bought for about EUR 25.65 on popular exchanges. Current supply of Schott Pharma & stocks is 150.6 mn. Schott Pharma & has a current market capitalization of EUR 3.8 bn and approximately EUR 1.7 mn worth of Schott Pharma & was traded on exchanges in the last 24 hours. Since last month end, Schott Pharma & has traded 2 % up. Simple moving average of last 200 days is at EUR 18.34. The highest price of past 52 weeks was recorded at EUR 26.2 on 10/21/2026. 52 weeks low was at EUR 12.62 on 03/23/2026.
Here is how related stocks have performed in the past 24 hours:
Wacker Chemie (WCH.DE) traded up 2.79 % and now trades at EUR 82.4. Wacker Chemie has a market capitalisation of EUR 4 bn.
Krones (KRN.DE) traded up 1.63 % and now trades at EUR 112.5. Current market capitalisation for Krones is EUR 3.5 bn. Current price/earnings ratio for Krones is 12.13. KRONES AG, a German manufacturer of beverage dispensing systems, reported a robust quarterly performance. The company highlighted continued growth in its core product lines and noted that order volumes are rising, reflecting stronger demand from the hospitality and foodservice sectors. KRONES emphasized its commitment to innovation, particularly in digital solutions that enhance customer experience. The management also reiterated confidence in the upcoming fiscal year, citing a solid pipeline and strategic investments aimed at sustaining market leadership. Despite broader market volatility, KRONES maintained a positive outlook, underscoring its resilience in a competitive landscape.
Puma (PUM.DE) traded up 1.84 % and now trades at EUR 24.84. Puma has a market capitalisation of EUR 3.8 bn. Puma SE’s share price has begun to recover after a prolonged period of weakness. Recent developments, including the entry of the Chinese sports‑wear group Anta Sports as a major shareholder, management changes, and a more positive short‑term price trend, have injected fresh optimism into the market. Several analysts now regard the company’s valuation as potentially higher than previously expected, suggesting that the restructuring process may be progressing more effectively than initially believed. While the exact extent of the corporate overhaul remains to be fully clarified, the current trajectory points toward a possible broader turnaround for the brand’s stock.
Springer Nature & (SPG.DE) traded up 0.24 % and now trades at EUR 20.7. Springer Nature & has a market capitalisation of EUR 4.1 bn. Current price/earnings ratio for Springer Nature & is 12.15.
Auto (AG1.DE) traded up 3.05 % and now trades at EUR 17.46. Current market capitalisation for Auto is EUR 3.8 bn. Auto has a current price to earnings ratio of 49.76. AUTO1 Group SE has announced a change in its voting‑rights structure, reporting that a major shareholder, represented by a U.S. financial institution, has increased its stake to just over one percent of the company’s equity. The disclosure, filed under German securities law, details the holder’s direct and indirect voting rights, including shares and various derivative instruments. The announcement also notes that the threshold for significant ownership was crossed in mid‑October, prompting the required regulatory notification. No further operational or financial developments were disclosed in the release. The update highlights the company’s compliance with disclosure requirements and the ongoing monitoring of shareholder composition, while leaving the broader market context, such as the recent performance of AUTO1 within the MDAX index, unchanged.
About Schott Pharma &
The Schott Pharma AG & Co. KGaA is a health care sector company located in Mainz, Germany. The company specializes in providing drug containment and drug delivery solutions. SCHOTT Pharma offers prefillable syringes, cartridges, vials, and ampoules for analytical, development, fill-and-finish, and regulatory services for pharmaceutical companies, biotechs, and CDMOs. The company serves customers worldwide and can be accessed through their website at www.schott-pharma.com . SCHOTT Pharma is listed on the Xetra stock exchange.